Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H White

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Circulation|April 5, 2012
Identifying risk factors for venous thromboembolismRichard H White
Annals of Internal Medicine|July 21, 2010
Therapeutics. Review: heparin and mechanical compression are similar in reducing postsurgical VTE risk, but heparin increases bleedingRichard H White
Evidence-Based Medicine|October 7, 2008
Risk of fatal pulmonary embolism was 0.49 per 100 person-years after discontinuing anticoagulant therapy for venous thromboembolismRichard H White
ACP Journal Club|November 3, 2004
Men had greater risk for recurrent venous thromboembolism than womenRichard H White
Annals of Internal Medicine|December 16, 2014
Review: vitamin K antagonists increase risk for subdural hematoma compared with other antithromboticsRichard H White
ACP Journal Club|January 6, 2007
Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolismRichard H White
Annals of Internal Medicine|May 1, 2023
In adults with VTE who received anticoagulants for ≥3 mo, VTE-PREDICT predicted recurrence and bleeding at up to 5 yRichard H White
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Scores poorly predict major bleeding (c-statistics ≤ 0.61) during oral anticoagulant therapyRichard H White
Annals of Internal Medicine|May 17, 2016
Evidence-Based Guideline: CHEST made 20 strong recommendations about antithrombotic therapy for VTERichard H White
Circulation|June 20, 2003
The epidemiology of venous thromboembolismRichard H White
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Circulation|April 5, 2012
Identifying risk factors for venous thromboembolismRichard H White
Annals of Internal Medicine|July 21, 2010
Therapeutics. Review: heparin and mechanical compression are similar in reducing postsurgical VTE risk, but heparin increases bleedingRichard H White
Evidence-Based Medicine|October 7, 2008
Risk of fatal pulmonary embolism was 0.49 per 100 person-years after discontinuing anticoagulant therapy for venous thromboembolismRichard H White
ACP Journal Club|November 3, 2004
Men had greater risk for recurrent venous thromboembolism than womenRichard H White
Annals of Internal Medicine|December 16, 2014
Review: vitamin K antagonists increase risk for subdural hematoma compared with other antithromboticsRichard H White
ACP Journal Club|January 6, 2007
Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolismRichard H White
Annals of Internal Medicine|May 1, 2023
In adults with VTE who received anticoagulants for ≥3 mo, VTE-PREDICT predicted recurrence and bleeding at up to 5 yRichard H White
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Scores poorly predict major bleeding (c-statistics ≤ 0.61) during oral anticoagulant therapyRichard H White
Annals of Internal Medicine|May 17, 2016
Evidence-Based Guideline: CHEST made 20 strong recommendations about antithrombotic therapy for VTERichard H White
Circulation|June 20, 2003
The epidemiology of venous thromboembolismRichard H White
Pageof 13